New Brunswick Government Bets on Organigram with $2M Grant

MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow rooms, seeks to lift output by 10% while sharpening operational edges in a competitive market.

Opportunities New Brunswick, the province’s business development arm, approved the non-repayable grant during a facility tour led by Premier Susan Holt. The initiative replaces 9,000 outdated LED fixtures with advanced, high-output models, a move executives say will trim energy waste and accelerate harvest cycles to about 63 days per round. With each room housing more than 800 plants, the changes position the 210,000-square-foot complex to surpass 100 million grams of annual production this year, a site record.

Holt framed the backing as a calculated bet on returns, projecting a $3.37 million bump to the province’s gross domestic product by the end of 2026, alongside $424,000 in fresh tax receipts from direct and ripple effects. “Organigram keeps testing limits and aiming higher,” she said during the announcement. “This work solidifies its Moncton base, raises efficiency, and backs solid employment. When top firms pick New Brunswick to expand, it confirms we’re a sharp, results-driven spot for business.”

The project arrives as Organigram, founded in 2013 and bolstered by over $345 million from British American Tobacco since 2021, navigates a maturing industry. Third-quarter results for 2025 showed net revenue climbing 72% to $70.8 million year-over-year, fueled by strong sales in recreational and medical channels across Canada and exports to markets like Australia and Germany. Yet a $6.3 million net loss [up sharply from prior gains] stemmed from non-cash hits tied to derivatives and share valuations, underscoring the sector’s volatility despite revenue gains.

At the Moncton plant, which employs more than 700 workers with room for expansion, the upgrades underscore a push for precision agriculture. From an industry standpoint, the deal reflects Cannabis’s integration into provincial economies seven years post-legalization. New Brunswick alone has pulled in over $144 million from its cut of federal excise duties since 2018, proof of the crop’s fiscal weight.

Critically, this infusion arrives when many producers grapple with oversupply and price squeezes, making efficiency plays like Organigram’s not merely additive but essential for survival. The 10% yield gain, if realized, could translate to millions in extra revenue, bolstering cash flow for innovation in edibles, vapes, and international medical lines. Yet success depends on those trade reforms; without them, provincial silos risk capping the sector’s potential at a time when global demand calls for unified Canadian strategy.

Wrapping up, the Organigram’s move in Moncton signals a steady hand in an uneven field. As governments like New Brunswick lean in with targeted aid, it spotlights Cannabis as a reliable engine for jobs and growth, one upgrade at a time.